Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NasdaqGM - Delayed Quote USD

Prenetics Global Limited (PRE)

5.40
+0.08
+(1.50%)
At close: May 5 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
30,621
30,621
21,742.68
13,163.84
12,532.74
Cost of Revenue
15,221
15,221
12,912.79
9,545.55
8,930.15
Gross Profit
15,400
15,400
8,829.89
3,618.30
3,602.60
Operating Expense
66,289
66,289
61,235.19
69,533.96
60,054.34
Operating Income
-50,889
-50,889
-52,405.31
-65,915.67
-56,451.74
Net Non Operating Interest Income Expense
1,836
1,836
3,803.62
-3,522.88
-5,051.88
Other Income Expense
-8,649
-8,649
-8,067.34
-156,381.61
-155,049.91
Pretax Income
-57,702
-57,702
-56,669.03
-225,820.15
-216,553.52
Tax Provision
-7,874
-7,874
-269.36
-244.82
2,568.52
Net Income Common Stockholders
-46,304
-46,304
-62,723.87
-190,453.33
-174,009.27
Diluted NI Available to Com Stockholders
-46,304
-46,304
-62,723.87
-190,453.33
-174,009.27
Basic EPS
-3.71
--
-5.58
-37.57
-23.52
Diluted EPS
-3.71
--
-5.58
-37.57
-23.52
Basic Average Shares
12,494.65
--
11,246.01
5,069.32
7,398.62
Diluted Average Shares
12,494.65
--
11,246.01
5,069.32
7,398.62
Total Operating Income as Reported
-48,144
-48,144
-51,906.72
-66,020.49
-56,661.85
Total Expenses
81,510
81,510
74,147.98
79,079.51
68,984.48
Net Income from Continuing & Discontinued Operation
-46,304
-46,304
-62,723.87
-190,453.33
-174,009.27
Normalized Income
-37,449.67
-37,449.67
-47,027.34
-129,313.06
-194,341.45
Interest Income
2,039
2,039
3,923.28
471.88
0.20
Interest Expense
203
203
119.66
242
42.23
Net Interest Income
1,836
1,836
3,803.62
-3,522.88
-5,051.88
EBIT
-57,499
-57,499
-56,549.37
-225,578.16
-216,511.29
EBITDA
-51,570
-51,570
-48,755
-218,035.18
-209,164.65
Reconciled Cost of Revenue
15,221
15,221
12,912.79
9,545.55
8,930.15
Reconciled Depreciation
5,929
5,929
7,794.37
7,542.98
7,346.64
Net Income from Continuing Operation Net Minority Interest
-46,326
-46,326
-54,346.21
-225,575.28
-219,114.48
Total Unusual Items Excluding Goodwill
-10,279
-10,279
-7,353.83
-96,366.70
-29,668.29
Total Unusual Items
-10,279
-10,279
-7,353.83
-96,366.70
-29,668.29
Normalized EBITDA
-41,291
-41,291
-41,401.17
-121,668.48
-179,496.36
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-1,402.67
-1,402.67
-34.95
-104.47
-4,895.27
12/31/2021 - 7/16/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

RNVA Rennova Health, Inc.
0.0001
0.00%
 
RSHN RushNet, Inc.
0.0002
0.00%
 
GENE Genetic Technologies Limited
0.7650
0.00%
 
STRR Star Equity Holdings, Inc.
2.2600
+0.89%
 
OCX OncoCyte Corporation
2.9200
-4.26%
 
SONA.CN Sona Nanotech Inc.
0.3000
+1.69%
 
BDSX Biodesix, Inc.
0.4743
-8.44%
 
BIAF bioAffinity Technologies, Inc.
0.3800
-15.27%
 
ISPC iSpecimen Inc.
1.2200
-2.40%
 
PRPO Precipio, Inc.
6.31
-11.75%